Bi-anti therapy for SARS-CoV-2 infection among mild/moderate patients to prevent coronavirus disease 2019 from progressing to severe disease

Detalles Bibliográficos
Autor principal: Xu, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900530/
https://www.ncbi.nlm.nih.gov/pubmed/36747253
http://dx.doi.org/10.1186/s12967-023-03965-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900530/
https://www.ncbi.nlm.nih.gov/pubmed/36747253
http://dx.doi.org/10.1186/s12967-023-03965-3

Ejemplares similares